A Formulation Scientist plays a vital role in the development of safe and effective therapeutic products. Their primary responsibility is to design and optimize the composition of drugs to ensure stability, bioavailability, and patient compliance. This involves selecting suitable excipients, determining the right dosage form (such as tablets, capsules, or injectables), and understanding the physicochemical properties of active pharmaceutical ingredients. The goal is to create a product that delivers the desired therapeutic effect consistently and reliably over its shelf life. These professionals also conduct rigorous compatibility and stability testing under various environmental conditions to guarantee product integrity. Their work ensures not only the quality of the medication but also its effectiveness and ease of administration. Innovation is also key, as they may explore new delivery systems like nanocarriers or controlled-release mechanisms.
Formulation Scientist collaborates closely with analytical chemists, process engineers, and regulatory teams throughout the development lifecycle. They must consider factors like manufacturability, scalability, and regulatory compliance, ensuring the final product meets global health standards. They contribute to drafting technical documents and supporting regulatory submissions, playing a crucial role in bringing new treatments from concept to market. With advances in biotechnology, personalized medicine, and novel drug delivery systems, the role continues to evolve—demanding not only scientific expertise but also innovation and adaptability in a highly regulated and competitive environment.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia